WASHINGTON (Reuters) - U.S. President Donald Trump on Monday renewed his criticism against drugmakers over medicine prices and vowed action, but gave no other details about his long-touted plan to address price hikes.
Trump had vowed in May that drug companies would soon be slashing prices. During his presidential campaign, he promised lower U.S. drug costs, but prices remain high.
(Reporting by Susan Heavey; Editing by David Gregorio)
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)